Skip To Main Content
Rahul Patel on Muck Rack

Rahul Patel

Sunnydale
As seen in: Ampere Analysis, Medium, Forbes, Nature, Wiley Online Library, American Journal of Health-System Pharmacy, British Pharmacological Society, CNET, PLOS, Annals of the Rheumatic Diseases, European Journal of Hospital Pharmacy and
Senior Analyst @AmpereAnalysis | Now and then, occasionally, sometimes I write about movies and TV | he/him
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rahul

Contact Rahul, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Difference Between IVF and IUI: Which is Right for You?

|
By Rahul Patel
| kalyanwomenshospital.com
Nowadays, the internet has made fertility-related information more easily available than ever. Reading articles, watching videos, or hearing success stories on social media helps you to learn about fertility treatment, but it can also confuse you. That confusion is something we see every day in our fertility clinic.
Open in Who Shared Issue with article?

Morgan Lewis Advises NuCube Energy, Inc. on de-SPAC Transaction

|
By Todd A. Hentges, Rahul Patel, Tara R. McElhiney
| morganlewis.com
NEW YORK, June 25, 2026: Morgan Lewis advised nuclear technology company NuCube Energy, Inc. on the signing of a business combination agreement with Launch Two Acquisition Corp., a special purpose acquisition company (SPAC). The transaction values NuCube at a pre-money equity value of approximately $500 million.
Open in Who Shared Issue with article?

Morgan Lewis Advises uniQure on $259M Follow-On Offering

|
By Timothy Corbett, Rahul Patel, Richard Zarin
| morganlewis.com
LONDON, June 25, 2026: Morgan Lewis represented uniQure N.V. in connection with its upsized SEC-registered follow-on offering of 5,686,813 ordinary shares at a price of $45.50 per share. This included 741,758 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares. The aggregate gross proceeds to the company were approximately $259 million.
Open in Who Shared Issue with article?
See all 334 licensed articles (337 Total)